Stoke Therapeutics grants CSO McCauley options for 225,000 shares at $29.91 each
STOK•Stock options granted to new Chief Scientific Officer
Stoke Therapeutics granted stock options on July 15, 2026 to new hires, led by newly appointed Chief Scientific Officer Thomas McCauley.
McCauley received options for 225,000 shares at an exercise price of $29.91, matching the July 15 close.
Seven additional employees received options for 83,070 shares at $29.91.
Awards vest over four years: 25% after one year, then monthly over the next 36 months; options run for 10 years.
